U-Chart Analysis:KYORIN Holdings,Inc.:4569

※The values of financial statements might be different from the actual ones. Please confirm the original. [instructions]

Main FunctionHelp Company NameHelp CodeHelp Types of IndustryHelp Market Name Fiscal Year End Year of Listing
Browse U-Chart Add to 'Companies Comparison' list Compare Lustrum Ullet index KYORIN Holdings,Inc. Go to web site 4569 Medicals 1st TSE March 1, 2000 2006.
Analysis u.gifU-Chart AnalysisHelp hikaku.gifAdd to 'Companies Comparison' listHelp u2.gifCompare LustrumHelp mark.gifUllet indexHelp
Accounts Information Balance Sheet Profit and Loss Account Cash Flow Statement
Display

KYORIN Holdings,Inc. Balance Sheet(B/S)

[Show - Hide] U-Chart:Balance Sheet (B/S)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

KYORIN Holdings,Inc. Balance Sheet 2020年3月期 KYORIN Holdings,Inc. Balance Sheet 2019年3月期 KYORIN Holdings,Inc. Balance Sheet 2018年3月期 KYORIN Holdings,Inc. Balance Sheet 2017年3月期 KYORIN Holdings,Inc. Balance Sheet 2016年3月期

[Show - Hide] Balance Sheet (B/S)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2020 March 31, 2019 March 31, 2018 March 31, 2017 March 31, 2016
Cash and Cash Equivalents 31,925 32,007 44,117 43,619 45,712
Other Current AssetsHelp 85,133 82,897 75,829 82,648 92,771
Tangible Fixed AssetsHelp 22,721 21,792 21,901 22,432 22,788
Intangible Fixed AssetHelp 3,332 3,401 1,750 1,204 1,201
Investments and OthersHelp 28,049 32,937 53,139 42,765 35,353
Total AssetsHelp 171,160 173,034 196,736 192,668 197,825
Total Current LiabilitiesHelp 47,912 49,263 33,439 34,353 40,233
Total Long-term LiabilitiesHelp 538 376 0 478 543
Shareholder's EquityHelp 122,710 123,395 163,297 157,837 157,049
Total LiabilitiesHelp 171,160 173,034 196,736 192,668 197,825

KYORIN Holdings,Inc. Profit and Loss Account(P/L)

[表示非表示] U-Chart:Profit and Loss Account (P/L)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

KYORIN Holdings,Inc. Profit and Loss Account 2020年3月期 KYORIN Holdings,Inc. Profit and Loss Account 2019年3月期 KYORIN Holdings,Inc. Profit and Loss Account 2018年3月期 KYORIN Holdings,Inc. Profit and Loss Account 2017年3月期 KYORIN Holdings,Inc. Profit and Loss Account 2016年3月期

[Show - Hide] Profit and Loss Account (P/L)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2020 March 31, 2019 March 31, 2018 March 31, 2017 March 31, 2016
Amount of Sales 109,983 113,620 110,640 115,373 119,483
Total Sales 109,983 113,620 110,640 115,373 119,483
Cost of SalesHelp 52,950 56,210 49,064 50,847 47,360
Other Costs and RevenueHelp 50,884 50,541 55,002 57,221 58,483
Total CostsHelp 103,834 106,751 104,066 108,068 105,843
Net RevenueHelp 57,033 57,410 61,576 64,526 72,123
Earnings Before TaxHelp 8,255 9,359 9,061 9,716 18,815
Net IncomeHelp 6,149 6,869 6,574 7,305 13,640
Net Income 6,149 6,869 6,574 7,305 13,640

KYORIN Holdings,Inc. Cash Flow Statement(C/F)

[表示非表示] U-Chart:Cash Flow Statement (C/F)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

KYORIN Holdings,Inc. Cash Flow Statement 2020年3月期 KYORIN Holdings,Inc. Cash Flow Statement 2019年3月期 KYORIN Holdings,Inc. Cash Flow Statement 2018年3月期 KYORIN Holdings,Inc. Cash Flow Statement 2017年3月期 KYORIN Holdings,Inc. Cash Flow Statement 2016年3月期

[Show - Hide] Cash Flow Statement (C/F)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2020 March 31, 2019 March 31, 2018 March 31, 2017 March 31, 2016
Operating Cash Flow(OFC)Help 7,678 341 10,454 16,385 11,137
Investing Cash Flow(ICF)Help -2,943 14,939 -6,038 -13,142 650
Financing Cash FlowHelp -5,117 -27,315 -3,735 -5,721 -2,245
Exchange Difference of Cash and Cash EquivalentsHelp -22 -22 -210 -65 -226
Net Increase and Decrease in Cash and Cash Equivalentsn -404 -12,057 471 -2,543 9,316

他社比較Help

Companies in 'Companies Comparison' list

Browsing historyHelp

Your reecently viewed companies

KYORIN Holdings,Inc.

Company where related level is highHelp

Chiome Bioscience Inc.
GNI Group Ltd.
ZERIA PHARMACEUTICAL CO.,LTD.
Shionogi & Co.,Ltd.
SymBio Pharmaceuticals Limited
TAISHO PHARMACEUTICAL HOLDINGS CO., LTD.
AnGes,Inc.
SSP CO.,LTD.
Fuji Pharma Co.,Ltd.
D.Western Therapeutics Institute, Inc.